ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 1121

$1.09M Total Retail Price of All Prescriptions

Rank: 51 out of 1121

811 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 811 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 811 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,374 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
WARFARIN SODIUM 798 627 1 11
LEVOTHYROXINE SODIUM 790 636 2 2
LISINOPRIL 771 582 3 4
HYDROCODONE-ACETAMINOPHEN 620 433 S3 4 3
FUROSEMIDE 606 505 5 7
SIMVASTATIN 581 460 6 1
OMEPRAZOLE 569 458 7 6
AMLODIPINE BESYLATE 477 406 8 5
METFORMIN HCL 414 301 9 8
METOPROLOL TARTRATE 406 338 10 9
PRAVASTATIN SODIUM 376 321 11 14
CITALOPRAM HBR 326 279 12 18
POLYETHYLENE GLYCOL 3350 321 298 13 70
POTASSIUM CHLORIDE 291 233 14 12
GLIMEPIRIDE 261 203 15 34
ATENOLOL 244 202 16 16
GABAPENTIN 238 208 17 13
ZOLPIDEM TARTRATE 233 183 18 19
ATORVASTATIN CALCIUM 226 202 19 15
LANTUS 225 191 20 52
NEXIUM 223 160 21 24
NAMENDA 214 214 22 53
RANITIDINE HCL 204 174 23 33
HYDROCHLOROTHIAZIDE 175 162 24 10
CRESTOR 169 107 25 28
SERTRALINE HCL 159 144 26 21
CARVEDILOL 158 118 27 20
DONEPEZIL HCL 158 158 27 35
DIOVAN 156 124 29 45
NOVOLOG 153 119 30 139
FLUTICASONE PROPIONATE 144 124 31 36
MIRTAZAPINE 140 140 32 56
ESCITALOPRAM OXALATE 140 137 32 94
TRAZODONE HCL 134 107 34 40
LOSARTAN POTASSIUM 134 101 34 17
PREDNISONE 126 88 36 43
EXELON 123 123 37 119
CLOPIDOGREL 121 101 38 27
CLONIDINE HCL 120 115 39 39
METOPROLOL SUCCINATE 120 109 39 23
TAMSULOSIN HCL 115 113 41 32
PROMETHAZINE HCL 115 77 R 41 67
ZETIA 105 62 43 80
BENAZEPRIL HCL 105 92 43 41
CYCLOBENZAPRINE HCL 104 26 R 45 83
AMLODIPINE BESYLATE-BENAZEPRIL 104 92 45 65
RISPERIDONE 102 94 47 82
PANTOPRAZOLE SODIUM 100 91 48 29
CIPROFLOXACIN HCL 98 87 49 57
PLAVIX 96 72 50 42
ACTOS 95 74 51 133
AZITHROMYCIN 94 56 52 44
CARBIDOPA-LEVODOPA 92 91 53 118
LEVOFLOXACIN 90 75 54 79
LOVASTATIN 89 81 55 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 78 56 31
ALLOPURINOL 87 70 56 30
KLOR-CON 10 86 70 58 69
LEVETIRACETAM 82 40 59 125
TRICOR 81 38 60 126
GLIPIZIDE 79 47 61 84
FLUOXETINE HCL 78 37 62 60
TRIAMTERENE-HCTZ 78 64 62 38
SINGULAIR 77 58 64 78
KLOR-CON M20 77 68 64 85
QUETIAPINE FUMARATE 75 66 66 75
TORSEMIDE 74 62 67 155
DILTIAZEM 24HR CD 73 72 68 99
SPIRIVA 73 67 68 49
CEPHALEXIN 71 57 70 111
JANTOVEN 71 70 70 146
AMITRIPTYLINE HCL 70 59 R 72 61
ALBUTEROL SULFATE 70 66 72 141
INSULIN SYRINGE 69 47 74 77
METFORMIN HCL ER 68 43 75 47
DOXYCYCLINE HYCLATE 68 49 75 103
NOVOLIN R 67 65 77 174
TRAMADOL HCL 66 57 78 25
FENOFIBRATE 66 38 78 71
ROPINIROLE HCL 66 53 78 91
DIVALPROEX SODIUM 61 49 81 98
DIOVAN HCT 61 56 81 90
PROAIR HFA 59 34 83 48
LANTUS SOLOSTAR 59 35 83 109
PAROXETINE HCL 57 52 85 58
LEVEMIR 57 49 85 157
CYMBALTA 57 50 85 50
PHENYTOIN SODIUM EXTENDED 56 32 88 135
ISOSORBIDE MONONITRATE ER 54 36 89 62
IPRATROPIUM-ALBUTEROL 54 35 89 160
OLANZAPINE 52 52 91 181
COMBIVENT 52 32 91 129
KLOR-CON M10 52 51 91 171
PRAMIPEXOLE DIHYDROCHLORIDE 50 39 94 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.